2CT-2-EtO
Pharmaceutical compound
From Wikipedia, the free encyclopedia
2CT-2-EtO, also known as 2-ethoxy-5-methoxy-4-methylthiophenethylamine, is a psychoactive drug of the phenethylamine, 2C, and TWEETIO families related to the psychedelic drug 2C-T.[1][2][3] It is the derivative of 2C-T in which the methoxy group at the 2 position has been replaced with an ethoxy group.[1][2][3]
- None
| |
| Clinical data | |
|---|---|
| Other names | 2CT-2EtO; 2CT-2-ETO; 2CT-2ETO; 2C-T-2-EtO; 2-Ethoxy-5-methoxy-4-methylthiophenethylamine; 2-Ethoxy-4-methylthio-5-methoxyphenethylamine |
| Routes of administration | Oral[1][2][3] |
| Drug class | Psychoactive drug |
| ATC code |
|
| Pharmacokinetic data | |
| Onset of action | "Very quick"[1] |
| Duration of action | 4 hours[1][2][3] |
| Identifiers | |
| |
| Chemical and physical data | |
| Formula | C12H19NO2S |
| Molar mass | 241.35 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
According to Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, 2CT-2-EtO's dose is 50 mg orally and its duration is 4 hours.[1][2][3] It is said to have a "very quick" onset.[1] The effects of 2CT-2-EtO are said to be "mild", reaching no greater than a "plus-one" on the Shulgin Rating Scale, and were reported to include blurred vision, with no other specific effects described.[1][2][3] Higher doses of the drug were not assessed.[1][2][3]
The chemical synthesis of 2CT-2-EtO has been described.[1]
2CT-2-EtO was first described in the literature by Shulgin in PiHKAL in 1991.[1] It was developed and tested by Darrell Lemaire, with publication via personal communication with Shulgin.[2][4][5][6][7] The drug is a controlled substance in Canada under phenethylamine blanket-ban language.[8]